title: Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.
abstract: Plants of the genus Scutellaria constitute one of the common components of Eastern as well as traditional American medicine against various human diseases, including cancer. In this study, we examined the in vivo anti-glioma activity of a leaf extract of Scutellaria ocmulgee (SocL) while also exploring their potential molecular mechanisms of action. Oral administration of SocL extract delayed the growth of F98 glioma in F344 rats, both in intracranial and subcutaneous tumor models. Immunohistochemistry revealed inhibition of Akt, GSK-3α/β and NF-κB phosphorylation in the subcutaneous tumors following treatment with Scutellaria. The SocL extract as well as the constituent flavonoid wogonin also showed dose- and time-dependent inhibition of Akt, GSK-3α/β and NF-κB in F98 cell cultures in vitro, as determined by western blot analysis. Pharmacologic inhibitors of PI3K and NF-κB also significantly inhibited the in vitro proliferation of F98 glioma cells, indicating the key role of these signaling molecules in the growth of malignant gliomas. Transfection of F98 cells with constitutively active mutant of AKT (AKT/CA), however, did not significantly reverse Scutellaria-mediated inhibition of proliferation, indicating that Scutellaria flavonoids either directly inhibited Akt kinase activity or acted downstream of Akt. In vitro Akt kinase assay demonstrated that the SocL extract or wogonin could indeed bind to Akt and inhibit its kinase activity. This study provides the first in vivo evidence and mechanistic support for anti-glioma activity of Scutellaria flavonoids and has implications in potential usage of Scutellaria flavonoids in adjuvant therapy for malignant tumors, including gliomas.
authors.affiliation: Department of Neurosurgery, Wayne State University & Karmanos Cancer Institute, Detroit, MI, 48201, USA. pparajuli@med.wayne.edu
authors.forename: Prahlad
authors.initials: P
authors.lastname: Parajuli
authors.forename: N
authors.initials: N
authors.lastname: Joshee
authors.forename: S R
authors.initials: SR
authors.lastname: Chinni
authors.forename: A M
authors.initials: AM
authors.lastname: Rimando
authors.forename: S
authors.initials: S
authors.lastname: Mittal
authors.forename: S
authors.initials: S
authors.lastname: Sethi
authors.forename: A K
authors.initials: AK
authors.lastname: Yadav
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D005419:Flavonoids / Q000627:therapeutic use*; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D047468:Immunoprecipitation; D016328:NF-kappa B / Q000378:metabolism; D008517:Phytotherapy / Q000379:methods*; D010936:Plant Extracts / Q000627:therapeutic use; D018515:Plant Leaves / Q000737:chemistry; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D031363:Scutellaria / Q000737:chemistry*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D005419:Flavonoids; D016328:NF-kappa B; D010936:Plant Extracts; D051057:Proto-Oncogene Proteins c-akt; D038362:Glycogen Synthase Kinase 3
references.citation: Clin Cancer Res. 2002 Apr;8(4):1228-36
references.pmid: 11948137
references.citation: Eur J Pharmacol. 2008 Sep 4;591(1-3):7-12
references.pmid: 18577379
references.citation: Nat Rev Drug Discov. 2005 Dec;4(12):988-1004
references.pmid: 16341064
references.citation: Mol Nutr Food Res. 2008 Nov;52(11):1349-57
references.pmid: 18496814
references.citation: Mol Cell Biol. 2002 Jan;22(2):680-91
references.pmid: 11756562
references.citation: Phytomedicine. 2006 Feb;13(3):205-8
references.pmid: 16428031
references.citation: Int J Cancer. 2008 Feb 15;122(4):816-22
references.pmid: 17957784
references.citation: Am J Clin Nutr. 2001 Oct;74(4):418-25
references.pmid: 11566638
references.citation: Curr Neurol Neurosci Rep. 2008 May;8(3):264-8
references.pmid: 18541122
references.citation: Semin Radiat Oncol. 2010 Jan;20(1):58-66
references.pmid: 19959032
references.citation: Proc Natl Acad Sci U S A. 1977 Jul;74(7):3065-7
references.pmid: 197531
references.citation: Planta Med. 2009 Jan;75(1):41-8
references.pmid: 19031366
references.citation: Neurosurgery. 2004 Dec;55(6):1410-9; discussion 1419
references.pmid: 15574223
references.citation: Nat Clin Pract Neurol. 2007 Dec;3(12):682-93
references.pmid: 18046441
references.citation: Free Radic Biol Med. 2002 Dec 15;33(12):1693-702
references.pmid: 12488137
references.citation: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references.pmid: 13655060
references.citation: J Chromatogr B Biomed Sci Appl. 1998 Sep 4;714(2):369-74
references.pmid: 9766878
references.citation: Breast Cancer Res Treat. 2007 Sep;105(1):17-28
references.pmid: 17111207
references.citation: PLoS One. 2009 Oct 13;4(10):e7443
references.pmid: 19823589
references.citation: BMC Complement Altern Med. 2006 Aug 16;6:27
references.pmid: 16914050
references.citation: Blood. 2006 Dec 1;108(12):3700-6
references.pmid: 16931628
references.citation: Cancer Res. 2008 Aug 15;68(16):6643-51
references.pmid: 18701488
references.citation: Neuroscience. 2006 Jun 30;140(2):477-89
references.pmid: 16580779
references.citation: Blood. 2008 Feb 15;111(4):2354-63
references.pmid: 18070986
references.citation: Phytomedicine. 2003 Nov;10(8):640-9
references.pmid: 14692724
references.citation: Oncogene. 2005 Nov 14;24(50):7482-92
references.pmid: 16288295
references.citation: Expert Opin Biol Ther. 2007 Apr;7(4):439-48
references.pmid: 17373896
references.citation: Nature. 1999 Sep 2;401(6748):86-90
references.pmid: 10485711
references.citation: Can J Neurol Sci. 2007 Aug;34(3):296-306
references.pmid: 17803026
references.citation: J Biol Chem. 2002 Nov 1;277(44):41888-96
references.pmid: 12167628
references.citation: Nature. 1999 Sep 2;401(6748):82-5
references.pmid: 10485710
references.citation: Clin Cancer Res. 2009 Feb 1;15(3):887-97
references.pmid: 19188159
references.citation: Cancer Treat Rev. 2009 Feb;35(1):57-68
references.pmid: 19004559
references.citation: Biosci Biotechnol Biochem. 2006 Oct;70(10):2371-80
references.pmid: 17031041
references.citation: J Neurosurg. 2001 Sep;95(3):480-8
references.pmid: 11565871